Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
Nature Medicine|June 17, 2024
Enhancing pediatric access to cell and gene therapiesCrystal L Mackall, Catherine M Bollard, Nancy Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.
Transfusion|February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimensCharles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Journal of Proteomics|June 11, 2008
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patientsSusan E Abbatiello, Yuan-Xiang Pan, Mi Zhou, et al.
Pediatric Blood & Cancer|May 26, 2018
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemiaMatthew J Oberley, Paul S Gaynon, Deepa Bhojwani, et al.
The Pediatric Infectious Disease Journal|February 19, 2008
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapyRachel Rau, Courtney D Fitzhugh, Kristin Baird, et al.
Biomarker Research|August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG reportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimenH Joachim Deeg, Barry E Storer, Michael Boeckh, et al.
Leukemia & Lymphoma|March 20, 2023
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemiaRyan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, et al.
Pediatric Blood & Cancer|July 21, 2016
Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemiaWeili Sun, Etan Orgel, Jemily Malvar, et al.
Pageof 29